NCT02473939View on ClinicalTrials.gov

An Evaluation of VR942 in Healthy Volunteers and Patients With Mild Asthma

PHASE1CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

April 30, 2016

Conditions
Asthma
Interventions
DRUG

VR942 delivered via a Vectura Dry Powder Inhaler

DRUG

Placebo delivered via a Vectura Dry Powder Inhaler

Trial Locations (1)

Unknown

Vectura Study Site, London

Sponsors

Collaborators (1)

UCB Pharma
All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

lead

Vectura Limited

INDUSTRY